Literature DB >> 29897389

Functional immune characterization of HIV-associated non-small-cell lung cancer.

D J Pinato1, A Kythreotou2, F A Mauri3, E Suardi4, E Allara5, R J Shiner6, A U Akarca7, P Trivedi8, N Gupta8, A Dalla Pria4, T Marafioti7, P Oliveri9, T Newsom-Davis10, M Bower11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29897389      PMCID： PMC6005048          DOI： 10.1093/annonc/mdy125

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

Review 1.  Classifying Cancers Based on T-cell Infiltration and PD-L1.

Authors:  Michele W L Teng; Shin Foong Ngiow; Antoni Ribas; Mark J Smyth
Journal:  Cancer Res       Date:  2015-06-01       Impact factor: 12.701

2.  Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer.

Authors:  A Guihot; A-G Marcelin; M-A Massiani; A Samri; C Soulié; B Autran; J-P Spano
Journal:  Ann Oncol       Date:  2018-02-01       Impact factor: 32.976

3.  Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy.

Authors:  Janis M Taube; Alison Klein; Julie R Brahmer; Haiying Xu; Xiaoyu Pan; Jung H Kim; Lieping Chen; Drew M Pardoll; Suzanne L Topalian; Robert A Anders
Journal:  Clin Cancer Res       Date:  2014-04-08       Impact factor: 12.531

4.  HIV-related lung cancer in the era of highly active antiretroviral therapy.

Authors:  Mark Bower; Tom Powles; Mark Nelson; Pallav Shah; Sarah Cox; Sundhiya Mandelia; Brian Gazzard
Journal:  AIDS       Date:  2003-02-14       Impact factor: 4.177

5.  Nonsmall cell lung cancer from HIV-infected patients expressed programmed cell death-ligand 1 with marked inflammatory infiltrates.

Authors:  Charlotte Domblides; Martine Antoine; Cécile Hamard; Nathalie Rabbe; Anita Rodenas; Thibault Vieira; Perrine Crequit; Jacques Cadranel; Armelle Lavolé; Marie Wislez
Journal:  AIDS       Date:  2018-02-20       Impact factor: 4.177
  5 in total
  4 in total

Review 1.  Cancer immunotherapy of patients with HIV infection.

Authors:  M Gonzalez-Cao; J Martinez-Picado; N Karachaliou; R Rosell; A Meyerhans
Journal:  Clin Transl Oncol       Date:  2018-11-17       Impact factor: 3.405

2.  Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression.

Authors:  Marina Natoli; John Gallon; Haonan Lu; Ala Amgheib; David J Pinato; Francesco A Mauri; Teresa Marafioti; Ayse U Akarca; Ines Ullmo; Jacey Ip; Eric O Aboagye; Robert Brown; Anastasios Karadimitris; Sadaf Ghaem-Maghami
Journal:  J Immunother Cancer       Date:  2021-01       Impact factor: 13.751

3.  Lymphocytes Infiltration and Expression of PD-1 and PD-L1 in Colorectal Cancer Between HIV-Infected and Non-HIV-Infected Patients: A Propensity Score Matched Cohort Study.

Authors:  Ye Cao; Qian Wu; Shixian Lian; Li Deng
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244

Review 4.  Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment.

Authors:  Stefano Frega; Alessandra Ferro; Laura Bonanno; Valentina Guarneri; PierFranco Conte; Giulia Pasello
Journal:  Int J Mol Sci       Date:  2020-02-26       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.